Use of real-world evidence for oncology clinical decision making in emerging economies. 2021

Fernando Petracci, and Chirag Ghai, and Andrew Pangilinan, and Luis Alberto Suarez, and Roberto Uehara, and Marwan Ghosn
Breast Cancer Department, Instituto Alexander Fleming, Avenida Crámer 1180 Ciudad Autónoma de Buenos Aires. C.P. 1426, Argentina.

Real-world evidence (RWE) can provide insights into patient profiles, disease detection, treatment choice, dosing strategies, treatment sequencing, adverse event management and financial toxicity associated with oncology treatment. However, the full potential of RWE is untapped in emerging economies due to structural and behavioral factors. Structural barriers include lack of regulatory engagement, real-world data availability, quality and integrity. Behavioral barriers include entrenched healthcare professional behaviors that impede rapid RWE understanding and adoption. These barriers can be addressed with close collaboration of healthcare stakeholders; of whom, regulators need to be at the forefront given their ability to facilitate use of RWE in healthcare policy and legislation.

UI MeSH Term Description Entries
D008495 Medical Oncology A subspecialty of internal medicine concerned with the study of neoplasms. Oncology, Medical,Clinical Oncology,Oncology, Clinical
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D003906 Developing Countries Countries in the process of change with economic growth, that is, an increase in production, per capita consumption, and income. The process of economic growth involves better utilization of natural and human resources, which results in a change in the social, political, and economic structures. LMICs,Less-Developed Countries,Low Income Countries,Low and Middle Income Countries,Lower-Middle-Income Country,Middle Income Countries,Third-World Countries,Under-Developed Countries,Developing Nations,Least Developed Countries,Less-Developed Nations,Third-World Nations,Under-Developed Nations,Countries, Middle Income,Countries, Third-World,Country, Least Developed,Country, Less-Developed,Country, Low Income,Country, Lower-Middle-Income,Country, Middle Income,Country, Third-World,Country, Under-Developed,Developed Country, Least,Developing Country,Developing Nation,Least Developed Country,Less Developed Countries,Less Developed Nations,Less-Developed Country,Less-Developed Nation,Low Income Country,Lower Middle Income Country,Lower-Middle-Income Countries,Middle Income Country,Nation, Less-Developed,Nation, Third-World,Nation, Under-Developed,Third World Countries,Third World Nations,Third-World Country,Third-World Nation,Under Developed Countries,Under Developed Nations,Under-Developed Country,Under-Developed Nation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000066491 Clinical Decision-Making Process of formulating a diagnosis based on medical history and physical or mental examinations, and/or choosing an appropriate intervention. Medical Decision-Making,Clinical Decision Making,Decision-Making, Clinical,Decision-Making, Medical,Medical Decision Making
D016032 Randomized Controlled Trials as Topic Works about clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table. Clinical Trials, Randomized,Controlled Clinical Trials, Randomized,Trials, Randomized Clinical
D019317 Evidence-Based Medicine An approach of practicing medicine with the goal to improve and evaluate patient care. It requires the judicious integration of best research evidence with the patient's values to make decisions about medical care. This method is to help physicians make proper diagnosis, devise best testing plan, choose best treatment and methods of disease prevention, as well as develop guidelines for large groups of patients with the same disease. (from JAMA 296 (9), 2006) Medicine, Evidence-Based,Evidence Based Medicine,Medicine, Evidence Based

Related Publications

Fernando Petracci, and Chirag Ghai, and Andrew Pangilinan, and Luis Alberto Suarez, and Roberto Uehara, and Marwan Ghosn
August 2021, Journal of managed care & specialty pharmacy,
Fernando Petracci, and Chirag Ghai, and Andrew Pangilinan, and Luis Alberto Suarez, and Roberto Uehara, and Marwan Ghosn
September 2017, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research,
Fernando Petracci, and Chirag Ghai, and Andrew Pangilinan, and Luis Alberto Suarez, and Roberto Uehara, and Marwan Ghosn
December 2020, Journal of managed care & specialty pharmacy,
Fernando Petracci, and Chirag Ghai, and Andrew Pangilinan, and Luis Alberto Suarez, and Roberto Uehara, and Marwan Ghosn
January 2021, Frontiers in pharmacology,
Fernando Petracci, and Chirag Ghai, and Andrew Pangilinan, and Luis Alberto Suarez, and Roberto Uehara, and Marwan Ghosn
July 2004, Evidence-based nursing,
Fernando Petracci, and Chirag Ghai, and Andrew Pangilinan, and Luis Alberto Suarez, and Roberto Uehara, and Marwan Ghosn
January 2024, JCO clinical cancer informatics,
Fernando Petracci, and Chirag Ghai, and Andrew Pangilinan, and Luis Alberto Suarez, and Roberto Uehara, and Marwan Ghosn
March 2022, Clinical therapeutics,
Fernando Petracci, and Chirag Ghai, and Andrew Pangilinan, and Luis Alberto Suarez, and Roberto Uehara, and Marwan Ghosn
November 2017, Journal of the National Cancer Institute,
Fernando Petracci, and Chirag Ghai, and Andrew Pangilinan, and Luis Alberto Suarez, and Roberto Uehara, and Marwan Ghosn
January 2023, Expert opinion on drug safety,
Fernando Petracci, and Chirag Ghai, and Andrew Pangilinan, and Luis Alberto Suarez, and Roberto Uehara, and Marwan Ghosn
December 2023, Clinical and translational science,
Copied contents to your clipboard!